Anticancer and Anti-Metastatic Role of Thymoquinone: Regulation of Oncogenic Signaling Cascades by Thymoquinone

Farooqi, Ammad Ahmad; Attar, Rükset; Xu, Baojun

doi:10.3390/ijms23116311

Cited by 11 publications

(5 citation statements)

References 109 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Chen et al showed that thymoquinone inhibited oxidative stress, inflammatory response, and apoptosis through the p13K/Akt pathway [ 27 ] in MCF-7 cells, and thymoquinone increased ROS levels, leading to greater phosphorylation of p38-MAPK. When p38-MAPK was silenced, the ability of thymoquinone to induce apoptosis in cancer cells was diminished [ 28 ].…”

Section: Discussionmentioning

confidence: 99%

Phytochemical Targeting of Nerve Growth Factor by Thymoquinone and Cuscutin: A Molecular Dynamics Simulation Study

Begum,

Ramadoss,

Yadalam

et al. 2024

Cureus

View full text Add to dashboard Cite

Background Nerve growth factor (NGF) is a novel target of pain therapeutics for oral cancer, and it plays a main role in the nociception of chronic pain. Surgery, along with chemotherapy or radiotherapy, is the gold standard for treating patients, but the side effects are significant as well. Newer effective interventions with natural phytochemicals could improve patient compliance and enhance the quality of life among patients with oral cancer. A literature search revealed a positive correlation between NGF and oral cancer pain. Nigella sativa ( N. sativa ) and Cuscuta reflexa ( C. reflexa ) have proven anticancer effects, but their activity with NGF is unexplored. Aims and objectives We aimed to identify the potential phytochemicals in N. sativa and C. reflexa . We also checked the NGF-blocking activity of the phytochemicals. Molecular docking and molecular dynamic (MD) simulations evaluated the binding energy and stability between the NGF protein and selected phytochemical ligands. Materials and methods We obtained protein NGF structure from UniProt (ID: 4EDX, P01138, Beta-nerve growth factor), ligand (thymoquinone) structure using PubChem ID: 10281, and ligand (cuscutin) structure using PubChem ID: 66065. Maestro protein (Schrödinger Inc., Mannheim, Germany) was used for molecular docking. Desmond Simulation Package (Schrödinger Inc., Mannheim, Germany) was used to model MD for 100 nanoseconds (ns). We have assessed the interaction between the protein and ligands by root mean square deviation (RMSD) values. Results The interaction of thymoquinone and cuscutin with NGF was assessed. While interacting with thymoquinone, there was mild fluctuation from 0.6 Å to 2.5 Å up to 80 ns and ended up at 4.8 Å up to 100 ns. While interacting with cuscutin, mild fluctuation was seen from 0.8 Å to 4.8 Å till 90 ns and ended at 6.4 Å up to 100 ns. We found a stable interaction between our drug combination and the NGF receptor. Conclusion We have identified a stable interaction between thymoquinone, cuscutin, and NGF by our MD simulations. Hence, it could be used as an NGF inhibitor for pain relief and to control tumor progression. Further in vitro and in vivo evaluations of this novel drug combination with phytochemicals will help us understand their biological activities and potential clinical applications in oral cancer therapeutics.

show abstract

Section: Discussionmentioning

confidence: 99%

Phytochemical Targeting of Nerve Growth Factor by Thymoquinone and Cuscutin: A Molecular Dynamics Simulation Study

Begum,

Ramadoss,

Yadalam

et al. 2024

Cureus

View full text Add to dashboard Cite

show abstract

“…The importance of these signaling pathways in the development and progression of CRC has been widely reported in the literature [95,[104][105][106]. The results from recent studies indicate that these elements may be potential targets for TQ [107].…”

Section: Thymoquinone a Promising Candidate For The Treatment Of Colo...mentioning

confidence: 91%

Thymoquinone: A Promising Therapeutic Agent for the Treatment of Colorectal Cancer

Kurowska,

Madej,

Strzalka-Mrozik

2023

CIMB

View full text Add to dashboard Cite

Colorectal cancer (CRC) is one of the most commonly diagnosed cancers and is responsible for approximately one million deaths each year. The current standard of care is surgical resection of the lesion and chemotherapy with 5-fluorouracil (5-FU). However, of concern is the increasing incidence in an increasingly younger patient population and the ability of CRC cells to develop resistance to 5-FU. In this review, we discuss the effects of thymoquinone (TQ), one of the main bioactive components of Nigella sativa seeds, on CRC, with a particular focus on the use of TQ in combination therapy with other chemotherapeutic agents. TQ exhibits anti-CRC activity by inducing a proapoptotic effect and inhibiting proliferation, primarily through its effect on the regulation of signaling pathways crucial for tumor progression and oxidative stress. TQ can be used synergistically with chemotherapeutic agents to enhance their anticancer effects and to influence the expression of signaling pathways and other genes important in cancer development. These data appear to be most relevant for co-treatment with 5-FU. We believe that TQ is a suitable candidate for consideration in the chemoprevention and adjuvant therapy for CRC, but further studies, including clinical trials, are needed to confirm its safety and efficacy in the treatment of cancer.

show abstract

“…TQ is a strong antioxidant that inhibits inflammatory mediators and cancer cells from proliferation [34] and has wound healing action [35].…”

Section: Thymoquinone (Tq)mentioning

confidence: 99%

Review of Phyto-Medical Extracts’ and Compounds’ Anti-Radiation Properties

JILANI,

PACKIRISAMY

2024

Asian J Pharm Clin Res

View full text Add to dashboard Cite

Humans are routinely exposed to radiation when receiving cancer treatment, fighting nuclear weapons, exploring space, and flying. Radiation exposure damages biological components such as protein, lipids, and cell membranes because it causes oxidative stress and inflammatory mediators, which can lead to DNA destruction even at low concentrations. Protecting people from the harmful effects of radiation is a challenging task due to the plethora of side effects of the chemical compounds used to mitigate DNA damage in normal cells. Hospitals continue to utilize radiotherapy for cancer treatment; yet, the adverse effects of the radiation they emit have outweighed the benefits. Plant phytochemicals and their derivatives exhibit diverse biological functions, often perceived as innocuous due to their non-toxic nature within subcellular and cellular environments. Moreover, they possess the capability to mitigate radiation-induced damage. This review aims to delineate the radioprotective attributes of plant polyphenols and extracts, elucidating their mechanisms of action across various models.

show abstract

Anticancer and Anti-Metastatic Role of Thymoquinone: Regulation of Oncogenic Signaling Cascades by Thymoquinone

Cited by 11 publications

References 109 publications

Phytochemical Targeting of Nerve Growth Factor by Thymoquinone and Cuscutin: A Molecular Dynamics Simulation Study

Phytochemical Targeting of Nerve Growth Factor by Thymoquinone and Cuscutin: A Molecular Dynamics Simulation Study

Thymoquinone: A Promising Therapeutic Agent for the Treatment of Colorectal Cancer

Review of Phyto-Medical Extracts’ and Compounds’ Anti-Radiation Properties

Contact Info

Product

Resources

About